Host Features Affecting CAR T Cell Therapy of Hematological Malignancies

1,381
Total downloads
6,446
Total views and downloads

Articles

CASE REPORT

Accepted on 11 Aug 2025

Successful CD19 chimeric antigen receptor T-cell therapy following autologous stem cell transplantation in a secondary central nervous system lymphoma patient with COVID-19 infection: A case report and literature review

Xiaoning Wang
juan ren
Yuqi Wang
Minna Jing Luo
jing Li
pengcheng he

doi 10.3389/fonc.2025.1656034

CASE REPORT

Accepted on 24 Jul 2025

Extramedullary Relapse of Acute Lymphoblastic Leukemia Treated with a CAR-T Cell Therapy Bridge to Unrelated Cord Blood Transplantation: A Case Report and Review of the Literature

Huibo Li
Jie Liu
Dan Guo
Yanqiu Zhao
Qi Li
Sen Qi
Jinxiao Hou
Zhang Jian-ping
Shengjin Fan

doi 10.3389/fonc.2025.1508676

197 views

ORIGINAL RESEARCH

Published on 27 Feb 2025

Tumor gene expression signatures associated with outcome in large B−cell lymphoma treated with CD19-directed CAR T−cell therapy (axicabtagene ciloleucel)

Yuan Tian
Justin Budka
Frederick L. Locke
Jason R. Westin
Christina To
Gayatri Tiwari
Daqin Mao
Davide Bedognetti
Rhine R. Shen
1 more
Simone Filosto

doi 10.3389/fonc.2025.1519473

3,167 views
1 citation

CASE REPORT

Published on 05 Dec 2024

Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis

Danqing Kong
Nana Ping
Qian Zhu
Xiao Zhang
Junhong Li
Rui Zou
Depei Wu
Zhengming Jin
Changju Qu

doi 10.3389/fonc.2024.1491100

1,455 views

Share on

Frontiers in Oncology

Frontiers in Oncology

Hematologic Malignancies

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

6,446Topic views
4,439Article views
1,381Article downloads